Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Olivier Cuvillier

Showing results (1-10 of 56) with videos related to

Pageof 6
Sort By:
Expert Opinion on Therapeutic Targets|July 16, 2008
Downregulating sphingosine kinase-1 for cancer therapyOlivier Cuvillier
Anti-Cancer Drugs|December 13, 2006
Sphingosine kinase-1--a potential therapeutic target in cancerOlivier Cuvillier
Biochimica Et Biophysica Acta|January 18, 2003
Sphingosine in apoptosis signalingOlivier Cuvillier
Translational Andrology and Urology|February 21, 2017
The therapeutic potential of HIF-2 antagonism in renal cell carcinomaOlivier Cuvillier
Medecine Sciences : M/S|November 23, 2012
[Sphingosine 1-phosphate receptors: from biology to physiopathology]Olivier Cuvillier
Anti-Cancer Agents in Medicinal Chemistry|June 29, 2011
Hypoxia-inducible factors and sphingosine 1-phosphate signalingOlivier Cuvillier, Isabelle Ader
Pharmacological Research|April 5, 2003
Enzymes of sphingosine metabolism as potential pharmacological targets for therapeutic intervention in cancerOlivier Cuvillier, Thierry Levade
Biochemical and Biophysical Research Communications|January 18, 2006
Regulation by sphingosine 1-phosphate of Bax and Bad activities during apoptosis in a MEK-dependent mannerSusan Betito, Olivier Cuvillier
Methods in Molecular Biology (Clifton, N.J.)|April 25, 2012
Biochemical methods for quantifying sphingolipids: ceramide, sphingosine, sphingosine kinase-1 activity, and sphingosine-1-phosphateLeyre Brizuela, Olivier Cuvillier
Medecine Sciences : M/S|April 2, 2020
[Multiple sclerosis and immuno-modulators of sphingosine 1-phosphate receptors]Franck Talmont, Anastassia Hatzoglou, Olivier Cuvillier
Pageof 6

Showing results (1-10 of 56) with videos related to

Sort By:
Pageof 6
Expert Opinion on Therapeutic Targets|July 16, 2008
Downregulating sphingosine kinase-1 for cancer therapyOlivier Cuvillier
Anti-Cancer Drugs|December 13, 2006
Sphingosine kinase-1--a potential therapeutic target in cancerOlivier Cuvillier
Biochimica Et Biophysica Acta|January 18, 2003
Sphingosine in apoptosis signalingOlivier Cuvillier
Translational Andrology and Urology|February 21, 2017
The therapeutic potential of HIF-2 antagonism in renal cell carcinomaOlivier Cuvillier
Medecine Sciences : M/S|November 23, 2012
[Sphingosine 1-phosphate receptors: from biology to physiopathology]Olivier Cuvillier
Anti-Cancer Agents in Medicinal Chemistry|June 29, 2011
Hypoxia-inducible factors and sphingosine 1-phosphate signalingOlivier Cuvillier, Isabelle Ader
Pharmacological Research|April 5, 2003
Enzymes of sphingosine metabolism as potential pharmacological targets for therapeutic intervention in cancerOlivier Cuvillier, Thierry Levade
Biochemical and Biophysical Research Communications|January 18, 2006
Regulation by sphingosine 1-phosphate of Bax and Bad activities during apoptosis in a MEK-dependent mannerSusan Betito, Olivier Cuvillier
Methods in Molecular Biology (Clifton, N.J.)|April 25, 2012
Biochemical methods for quantifying sphingolipids: ceramide, sphingosine, sphingosine kinase-1 activity, and sphingosine-1-phosphateLeyre Brizuela, Olivier Cuvillier
Medecine Sciences : M/S|April 2, 2020
[Multiple sclerosis and immuno-modulators of sphingosine 1-phosphate receptors]Franck Talmont, Anastassia Hatzoglou, Olivier Cuvillier
Pageof 6